
First EORTC anal cancer-specific questionnaire validated
18 Nov 2022

EORTC Quality of Life Group celebrating 40 years
22 Sep 2022

EORTC Item Library provides considerable coverage of CTCAE side effects, new study finds
31 Aug 2022

PRESS RELEASE: Better treatment for better health: lifting the veil on treatment optimisation
27 Jun 2022

MSD’s KEYTRUDA® (pembrolizumab) Significantly Improved Disease-Free Survival (DFS) Versus Placebo as Adjuvant Therapy in Patients With Stage IB-IIIA Non-Small Cell Lung Cancer (NSCLC) Regardless of PD-L1 Expression
17 Mar 2022

PRESS RELEASE: European Organisation for Research and Treatment of Cancer (EORTC) and Pierre Fabre Partner to Address Treatment Gap for Stage 2 Melanoma Patients
29 Jun 2021

PRESS RELEASE: Sanofi partnering with leading academic cooperative groups to study amcenestrant in the adjuvant setting for patients with estrogen receptor positive breast cancer
4 Jun 2021

PRESS RELEASE: HSH Prince Albert II cedes Honorary Presidency of the EORTC Research Fund to HRH Princess Dina Mired
20 Apr 2021